As far as the authors are aware, there is, as yet, no dedicated blog to plant varieties. Therefore the following post has been prepared for the Kluwer Patents Blog in the expectation that some…
As previously reported in this blog, on 11 February 2026, the UK Supreme Court handed down its ruling in Emotional Perception AI Ltd v Comptroller General of Patents, Designs and Trade Marks [2026]…
On 19 February 2026, the English Court of Appeal (Arnold LJ presiding) handed down its decision in Salts v Pelican [2026] EWCA Civ 93 – an appeal against the first instance decision of Ian Karet (…
In a landmark ruling handed down on 11 February, the UK Supreme Court in [Emotional Perception AI v Comptroller General [2026] UKSC 3] has brought about a shift in the way that the …
Preliminary injunctions (“PIs”) matter in life sciences patent cases. As often as not, the party which prevails at this stage of the litigation will have the upper hand in settlement…
On 1 September 2025, Michael Tappin KC sitting as a Deputy Judge of the High Court handed down a judgment in favour of Bayer’s application to strike out Sandoz’s claim for an account of profits under…
Two recent patent decisions on opposite sides of the Atlantic - EcoFactor v. Google in the United States and Optis v. Apple in the United Kingdom - highlight a growing divergence in the role of…
The final week of July usually produces a flurry, and sometimes an avalanche, of decisions from the English Courts as Judges attempt to clear their desks before the holiday period. This year…
The Court of Appeal’s judgment in Optis Cellular Technology LLC v Apple Retail UK Ltd [2025] EWCA Civ 552, handed down on 1 May 2025, is arguably the most significant UK FRAND decision since Unwired…
In the UK, as well as in many other countries, being the first to market with a generic or biosimilar to a leading branded medicine is a critical strategy that can offer a major advantage to a…
